| 标题： | 乳腺导管内乳头状瘤诊治临床实践指南2021.V1（CSBrS-Guideline-06） |
| title： | Clinical Practice Guidelines for Intraductal Papilloma: Chinese Society of Breast Surgery （CSBrS）Practice Guidelines 2021 |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 标准指南 |
| classification： | Standard guideline |
| 领域： | 综合 |
| field： | Comprehensive guideline |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 中国乳腺外科临床实践指南以中国乳腺疾病专业医生为适用对象。 |
| Guide users： | clinicians specializing in breast diseases in China. |
| 证据分级方法： | Grading of Recommendations Assessment, Development and Evaluation (GRADE) system |
| Evidence grading method： | |
| 制定单位： | 中华医学会外科学分会乳腺外科学组 |
| Formulating unit： | Chinese Society of Breast Surgery （CSBrS） |
| 注册时间： | 2021-06-02 |
| Registration time： | |
| 注册编号： | IPGRP-2021CN137 |
| Registration number： | |
| 指南制订的目的： | 乳腺导管内乳头状瘤是一种常见的乳腺良性病变,占乳腺全部良性病变的5.3%[1]。因其易复发并可能伴随导管上皮不典型增生和/或癌变等病理改变，且穿刺活检诊断的低估率高[2-3]，所以在诊断和治疗方法上具有一定特殊性, 尚有一些临床问题存在争议。为规范乳腺导管内乳头状瘤的诊断和治疗，为乳腺专科医师的临床工作提供指导，中华医学会外科学分会乳腺外科学组通过收集文献和专家讨论确定了乳腺导管内乳头状瘤临床实践指南的关键临床问题，参照GRADE（Grading of Recommendations Assessment, Development and Evaluation）系统对相关证据进行评价，制定乳腺导管内乳头状瘤诊治临床实践指南（2021版）。旨在为国内乳腺外科医师临床工作提供参考。 |
| Purpose of the guideline： | Intraductal papilloma of the breast is relatively common, accounting for 5.3% of all benign breast diseases.[1] However, relapse readily occurs with pathological changes such as atypical ductal hyperplasia (ADH) and canceration, and the rate of underestimation of biopsy diagnosis is high . [2 3]Therefore, specific considerations are required for the diagnosis and treatment methods of intraductal papilloma, and some clinical problems with these methods remain controversial. To standardize the diagnosis and treatment of intraductal papilloma of the breast and provide a reference for the clinical work of breast specialists, Chinese Society of Breast Surgery has determined the key clinical issues of the clinical practice guidelines for intraductal papilloma of the breast through a literature search and expert discussion. The relevant evidence was evaluated with reference to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, and the Clinical Practice Guidelines for Intraductal Papilloma: Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2021 was formulated to provide a reference for the clinical work of breast surgeons in China. |
